XERENDIP INY 4UI FAM C/1 DABIGATRAN ETEXILATO 01% CAJA C/TUBO C/40 G

Description

01% CAJA C/TUBO C/40 G

se recomienda monitoreo de función hepática

Presentación: Caja Con Frasco Con 6 g

Presentación en caja con 5 piezas 2

PRADAXA® R 150 mg es un medicamento de uso oral que contiene Dabigatrán etexilato

XERENDIP INY 4UI FAM C/1 DABIGATRAN ETEXILATO 01% CAJA C/TUBO C/40 GPRINCIPIO ACTIVO: SOMATROPINA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy